This month, Virtual Mentor theme issue editor, Katie Falloon, a medical student at the Duke University School of Medicine, interviewed Dr. Thomas Price about the ethical and regulatory issues associated with assisted reproductive technologies (ART).
Dr Caleb Alexander examines the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.
A philosophy professor argues that prenatal genetic testing allows potentially painful afflictions to be discovered prior to birth and does not unjustly discriminate against disabled people.
Two bioethicists argue that prenatal disability screening promotes negativity toward the disabled and gives parents the ability to selectively form families.